Rapid Onset and Sustained Efficacy (ROSE) study: results of a randomised, multicentre trial comparing the effect of zoledronic acid or alendronate on bone metabolism in postmenopausal women with low bone mass

Author: Hadji P.  

Publisher: Springer Publishing Company

ISSN: 0937-941X

Source: Osteoporosis International, Vol.23, Iss.2, 2012-02, pp. : 625-633

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content